Examining opioid-involved overdose mortality trends prior to fentanyl: New York City, 2000–2015

2019 ◽  
Vol 205 ◽  
pp. 107614
Author(s):  
Ellenie Tuazon ◽  
Hillary V. Kunins ◽  
Bennett Allen ◽  
Denise Paone
2018 ◽  
Vol 2 (4) ◽  
Author(s):  
Kellie C Van Beck ◽  
John Jasek ◽  
Kristi Roods ◽  
Jennifer J Brown ◽  
Shannon M Farley ◽  
...  

Abstract Colorectal cancer (CRC) incidence rates are rising in younger Americans and mortality rates are increasing among younger white Americans. We used New York State Cancer Registry data to examine New York City CRC incidence and mortality trends among adults ages 20–54 years by race from 1976 to 2015. Annual percent change (APC) was considered statistically significant at P less than .05 using a two-sided test. CRC incidence increased among those ages 20–49 years, yet blacks had the largest APC of 2.2% (1993–2015; 95% confidence interval [CI] = 1.4% to 3.1%) compared with 0.5% in whites (1976–2015; 95% CI = 0.2% to 0.7%). Among those aged 50–54 years, incidence increased among blacks by 0.8% annually (1976–2015; 95% CI = 0.4% to 1.1%), but not among whites. CRC mortality decreased among both age and race groups. These findings emphasize the value of local registry data to understand trends locally, the importance of timely screening, and the need for clinicians to consider CRC among all patients with compatible signs and symptoms.


2005 ◽  
Vol 11 (2) ◽  
pp. 147-156 ◽  
Author(s):  
C. Hembree ◽  
S. Galea ◽  
J. Ahern ◽  
M. Tracy ◽  
T. Markham Piper ◽  
...  

2021 ◽  
Vol 9 ◽  
Author(s):  
Anant Dinesh ◽  
Taha Mallick ◽  
Tatiana M. Arreglado ◽  
Brian L. Altonen ◽  
Ryan Engdahl

Introduction: In the initial pandemic regional differences may have existed in COVID-19 hospitalizations and patient outcomes in New York City. Whether these patterns were present in public hospitals is unknown. The aim of this brief study was to investigate COVID-19 hospitalizations and outcomes in the public health system during the initial pandemic response.Methods: A retrospective review was conducted on COVID-19 admissions in New York City public hospitals during the exponential phase of the pandemic. All data were collected from an integrated electronic medical records system (Epic Health Systems, Verona, WI). Overall, 5,422 patients with at least one admission each for COVID-19 were reviewed, with a study of demographic characteristics (including age, gender, race, BMI), pregnancy status, comorbidities, facility activity, and outcomes. Data related to hospitalization and mortality trends were also collected from City of New York website. These data often involved more than one facility and/or service line resulting in more location or treatment facility counts than patients due to utilization of services at more than one location and transfers between locations and facilities.Results: Higher mortality was associated with increasing age with the highest death rate (51.9%) noted in the age group >75 years (OR 7.88, 95%CI 6.32–10.08). Comorbidities with higher mortality included diabetes (OR 1.5, 95% CI 1.33–1.70), hypertension (OR 1.62, 95% CI 1.44–1.83), cardiovascular conditions (OR 1.66, 95% CI 1.47–1.87), COPD (OR 1.86, 95% CI 1.39–2.50). It was deduced that 20% of all New York City COVID-19 positive admissions were in public health system during this timeframe. A high proportion of admissions (21.26%) and deaths (19.93%) were at Elmhurst Hospital in Queens. Bellevue and Metropolitan Hospitals had the lowest number of deaths, both in borough of Manhattan. Mortality in public hospitals in Brooklyn was 29.9%, Queens 28.1%, Manhattan 20.4%.Conclusion: Significant variations existed in COVID-19 hospitalizations and outcomes in the public health system in New York City during the initial pandemic. Although outcomes are worse with older age and those with comorbidities, variations in hospitals and boroughs outside of Manhattan are targets to investigate and strategize efforts.


2010 ◽  
Vol 13 (3) ◽  
pp. 546-554 ◽  
Author(s):  
Katherine Freeman ◽  
Joel Zonszein ◽  
Nadia Islam ◽  
Arthur E. Blank ◽  
Alvin H. Strelnick

2013 ◽  
Vol 132 (1-2) ◽  
pp. 53-62 ◽  
Author(s):  
Magdalena Cerdá ◽  
Yusuf Ransome ◽  
Katherine M. Keyes ◽  
Karestan C. Koenen ◽  
Melissa Tracy ◽  
...  

1992 ◽  
Vol 136 (6) ◽  
pp. 646-656 ◽  
Author(s):  
Beryl A. Koblin ◽  
John M. Morrison ◽  
Patricia E. Taylor ◽  
Rand L. Stoneburner ◽  
Cladd E. Stevens

2021 ◽  
Author(s):  
Alex S. Bennett ◽  
Joy Scheidell ◽  
Jeanette M. Bowles ◽  
Maria Khan ◽  
Alexis Roth ◽  
...  

Abstract Background Despite increased availability of take-home naloxone, many people who use opioids do so in unprotected contexts, with no other person who might administer naloxone present, increasing the likelihood that an overdose will result in death. Thus, there is a social nature to being “protected” from overdose mortality, which highlights the importance of identifying background factors that promote access to protective social networks among people who use opioids. Methods We used respondent-driven sampling to recruit adults residing in New York City who reported recent (past 3-day) nonmedical opioid use (n=575). Participants completed a baseline assessment that included past 30-day measures of substance use, overdose experiences, and number of “protected” opioid use events, defined as involving naloxone and the presence of another person who could administer it, as well as measures of network characteristics and social support. We used modified Poisson regression with robust variance to estimate unadjusted and adjusted prevalence ratios (PRs) and 95% confidence intervals (CIs). Results 66% of participants had ever been trained to administer naloxone, 18% had used it in the past three months, and 32% had experienced a recent overdose (past 30 days). During recent opioid use events, 64% reported never having naloxone and a person to administer present. This was more common among those: aged ≥50 years (PR: 1.18 (CI: 1.03, 1.34); who identified as non-Hispanic Black (PR: 1.27 (CI: 1.05, 1.53); experienced higher levels of stigma consciousness (PR: 1.13 (CI: 1.00, 1.28); and with small social networks (<5 persons) (APR: 1.14 (CI: 0.98, 1.31). Having a recent overdose experience was associated with severe opioid use disorder (PR: 2.45 (CI: 1.49, 4.04), suicidality (PR: 1.72 (CI: 1.19, 2.49), depression (PR: 1.54 (CI: 1.20, 1.98) and positive urinalysis result for benzodiazepines (PR: 1.56 (CI: 1.23, 1.96), but not with network size. Conclusions Results show considerable gaps in naloxone protection among people who use opioids, with more vulnerable and historically disadvantaged subpopulations less likely to be protected. Larger social networks of people who use opioids may be an important resource to curtail overdose mortality, but more effort is needed to harness the protective aspects of social networks.


1942 ◽  
Vol 74 (3-4) ◽  
pp. 155-162
Author(s):  
H. Kurdian

In 1941 while in New York City I was fortunate enough to purchase an Armenian MS. which I believe will be of interest to students of Eastern Christian iconography.


Sign in / Sign up

Export Citation Format

Share Document